Diagnosis of Wilson Disease and Its Phenotypes by Using Artificial Intelligence

WD is caused by <i>ATP7B</i> variants disrupting copper efflux resulting in excessive copper accumulation mainly in liver and brain. The diagnosis of WD is challenged by its variable clinical course, onset, morbidity, and <i>ATP7B</i> variant type. Currently it is diagnosed b...

Full description

Bibliographic Details
Main Authors: Valentina Medici, Anna Czlonkowska, Tomasz Litwin, Cecilia Giulivi
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/11/8/1243
_version_ 1797524543390089216
author Valentina Medici
Anna Czlonkowska
Tomasz Litwin
Cecilia Giulivi
author_facet Valentina Medici
Anna Czlonkowska
Tomasz Litwin
Cecilia Giulivi
author_sort Valentina Medici
collection DOAJ
description WD is caused by <i>ATP7B</i> variants disrupting copper efflux resulting in excessive copper accumulation mainly in liver and brain. The diagnosis of WD is challenged by its variable clinical course, onset, morbidity, and <i>ATP7B</i> variant type. Currently it is diagnosed by a combination of clinical symptoms/signs, aberrant copper metabolism parameters (e.g., low ceruloplasmin serum levels and high urinary and hepatic copper concentrations), and genetic evidence of <i>ATP7B</i> mutations when available. As early diagnosis and treatment are key to favorable outcomes, it is critical to identify subjects before the onset of overtly detrimental clinical manifestations. To this end, we sought to improve WD diagnosis using artificial neural network algorithms (part of artificial intelligence) by integrating available clinical and molecular parameters. Surprisingly, WD diagnosis was based on plasma levels of glutamate, asparagine, taurine, and Fischer’s ratio. As these amino acids are linked to the urea–Krebs’ cycles, our study not only underscores the central role of hepatic mitochondria in WD pathology but also that most WD patients have underlying hepatic dysfunction. Our study provides novel evidence that artificial intelligence utilized for integrated analysis for WD may result in earlier diagnosis and mechanistically relevant treatments for patients with WD.
first_indexed 2024-03-10T08:58:56Z
format Article
id doaj.art-f055d13881ba441caff0e499490d4fc0
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-10T08:58:56Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-f055d13881ba441caff0e499490d4fc02023-11-22T06:56:53ZengMDPI AGBiomolecules2218-273X2021-08-01118124310.3390/biom11081243Diagnosis of Wilson Disease and Its Phenotypes by Using Artificial IntelligenceValentina Medici0Anna Czlonkowska1Tomasz Litwin2Cecilia Giulivi3Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of California Davis, Sacramento, CA 95817, USASecond Department of Neurology, Institute of Psychiatry and Neurology, 02-957 Warsaw, PolandSecond Department of Neurology, Institute of Psychiatry and Neurology, 02-957 Warsaw, PolandDepartment of Molecular Biosciences, School of Veterinary Medicine, University of California Davis, Davis, CA 95616, USAWD is caused by <i>ATP7B</i> variants disrupting copper efflux resulting in excessive copper accumulation mainly in liver and brain. The diagnosis of WD is challenged by its variable clinical course, onset, morbidity, and <i>ATP7B</i> variant type. Currently it is diagnosed by a combination of clinical symptoms/signs, aberrant copper metabolism parameters (e.g., low ceruloplasmin serum levels and high urinary and hepatic copper concentrations), and genetic evidence of <i>ATP7B</i> mutations when available. As early diagnosis and treatment are key to favorable outcomes, it is critical to identify subjects before the onset of overtly detrimental clinical manifestations. To this end, we sought to improve WD diagnosis using artificial neural network algorithms (part of artificial intelligence) by integrating available clinical and molecular parameters. Surprisingly, WD diagnosis was based on plasma levels of glutamate, asparagine, taurine, and Fischer’s ratio. As these amino acids are linked to the urea–Krebs’ cycles, our study not only underscores the central role of hepatic mitochondria in WD pathology but also that most WD patients have underlying hepatic dysfunction. Our study provides novel evidence that artificial intelligence utilized for integrated analysis for WD may result in earlier diagnosis and mechanistically relevant treatments for patients with WD.https://www.mdpi.com/2218-273X/11/8/1243Wilson diseasecoppermitochondrialiverintermediary metabolismurea cycle
spellingShingle Valentina Medici
Anna Czlonkowska
Tomasz Litwin
Cecilia Giulivi
Diagnosis of Wilson Disease and Its Phenotypes by Using Artificial Intelligence
Biomolecules
Wilson disease
copper
mitochondria
liver
intermediary metabolism
urea cycle
title Diagnosis of Wilson Disease and Its Phenotypes by Using Artificial Intelligence
title_full Diagnosis of Wilson Disease and Its Phenotypes by Using Artificial Intelligence
title_fullStr Diagnosis of Wilson Disease and Its Phenotypes by Using Artificial Intelligence
title_full_unstemmed Diagnosis of Wilson Disease and Its Phenotypes by Using Artificial Intelligence
title_short Diagnosis of Wilson Disease and Its Phenotypes by Using Artificial Intelligence
title_sort diagnosis of wilson disease and its phenotypes by using artificial intelligence
topic Wilson disease
copper
mitochondria
liver
intermediary metabolism
urea cycle
url https://www.mdpi.com/2218-273X/11/8/1243
work_keys_str_mv AT valentinamedici diagnosisofwilsondiseaseanditsphenotypesbyusingartificialintelligence
AT annaczlonkowska diagnosisofwilsondiseaseanditsphenotypesbyusingartificialintelligence
AT tomaszlitwin diagnosisofwilsondiseaseanditsphenotypesbyusingartificialintelligence
AT ceciliagiulivi diagnosisofwilsondiseaseanditsphenotypesbyusingartificialintelligence